DevaSharmaMDMaster of Science in Biotechnology
Hematology • Nashville, TNBlood Banking & Transfusion Medicine
Hematologist and Transfusion Medicine Physician
Dr. Sharma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1301 Medical Center Dr
Suite # 2603. TVC2 Hematology & Stem Cell Transplant Clinic
Nashville, TN 37232Phone+1 615-936-8422Fax+1 615-343-7200
Summary
- Dr. Deva Sharma is a physician at Vanderbilt University Medical Center who specializes in hematology-oncology and transfusion medicine. Her research and clinical interests are focused on the application of transfusion therapies for individuals with sickle cell disease and other red blood cell disorders.
Education & Training
Vanderbilt University Medical CenterFellowship, Blood Banking/Transfusion Medicine, 2018 - 2019- Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
University of Pittsburgh Post-Doctoral Fellowship, 2014 - 2015
University of Vermont Medical CenterResidency, Internal Medicine, 2011 - 2014
University of Maryland School of MedicineClass of 2011- Johns Hopkins University Master of Science, Biotechnology, 2005 - 2006
- University of Pennsylvania Bachelor of Arts and Sciences, Biology and French, with minor in South Asian Studies , 2000 - 2004
Certifications & Licensure
TN State Medical License 2019 - 2025
PA State Medical License 2014 - 2014
VT State Medical License 2011 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Pathology Blood Banking/Transfusion Medicine
Awards, Honors, & Recognition
- Medical Director of Vanderbilt Apheresis Clinic Vanderbilt University Medical Center
- Medical Director of Blood Bank Alvin C. York VA Medical Center
- Director of ACE Hematology Elective Course Vanderbilt University Medical Center
- Join now to see all
Clinical Trials
- Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease Start of enrollment: 2016 Sep 01
Publications & Presentations
PubMed
- Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditions.Jeremy W Jacobs, Garrett S Booth, Sheharyar Raza, Landon M Clark, Ross M Fasano
American Journal of Hematology. 2024-12-01 - Prophylactic red cell transfusions for sickle cell disease pregnancy: increased use of therapy could transform outcomes.Sheinei Alan, Deva Sharma, Lydia H Pecker
Current Opinion in Hematology. 2024-11-01 - 2 citationsCrizanlizumab and sickle cell disease: When should medications have their approval status revoked?Jeremy W Jacobs, Laura D Stephens, David M Chooljian, Deva Sharma, Brian D Adkins
American Journal of Hematology. 2024-06-01
Press Mentions
- British Society of Haematology Issues Updated Guidelines for Irradiated Blood ComponentsOctober 30th, 2020
Professional Memberships
- American Society of Hematology (ASH)Member
- Association for the Advancement of Blood and Biotherapies (AABB)Member
- American Society for Apheresis (AFSA)Member
Other Languages
- French, Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
